1. Home
  2. ARVN vs BSRR Comparison

ARVN vs BSRR Comparison

Compare ARVN & BSRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • BSRR
  • Stock Information
  • Founded
  • ARVN 2015
  • BSRR 1977
  • Country
  • ARVN United States
  • BSRR United States
  • Employees
  • ARVN N/A
  • BSRR N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • BSRR Major Banks
  • Sector
  • ARVN Health Care
  • BSRR Finance
  • Exchange
  • ARVN Nasdaq
  • BSRR Nasdaq
  • Market Cap
  • ARVN 456.2M
  • BSRR 416.7M
  • IPO Year
  • ARVN 2018
  • BSRR 1994
  • Fundamental
  • Price
  • ARVN $7.90
  • BSRR $30.35
  • Analyst Decision
  • ARVN Buy
  • BSRR Buy
  • Analyst Count
  • ARVN 22
  • BSRR 2
  • Target Price
  • ARVN $20.21
  • BSRR $33.50
  • AVG Volume (30 Days)
  • ARVN 1.8M
  • BSRR 24.5K
  • Earning Date
  • ARVN 10-29-2025
  • BSRR 10-20-2025
  • Dividend Yield
  • ARVN N/A
  • BSRR 3.30%
  • EPS Growth
  • ARVN N/A
  • BSRR 18.55
  • EPS
  • ARVN N/A
  • BSRR 2.90
  • Revenue
  • ARVN $372,800,000.00
  • BSRR $145,369,000.00
  • Revenue This Year
  • ARVN $4.87
  • BSRR $8.30
  • Revenue Next Year
  • ARVN N/A
  • BSRR $3.74
  • P/E Ratio
  • ARVN N/A
  • BSRR $10.43
  • Revenue Growth
  • ARVN 299.57
  • BSRR 2.12
  • 52 Week Low
  • ARVN $5.90
  • BSRR $22.42
  • 52 Week High
  • ARVN $29.61
  • BSRR $35.13
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 60.55
  • BSRR 54.10
  • Support Level
  • ARVN $7.62
  • BSRR $30.11
  • Resistance Level
  • ARVN $8.22
  • BSRR $31.17
  • Average True Range (ATR)
  • ARVN 0.31
  • BSRR 0.61
  • MACD
  • ARVN 0.10
  • BSRR 0.13
  • Stochastic Oscillator
  • ARVN 76.98
  • BSRR 65.69

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

Share on Social Networks: